Literature DB >> 19139311

Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease.

Shawn J Kile1, William G Ellis, John M Olichney, Sarah Farias, Charles DeCarli.   

Abstract

BACKGROUND: Neurofibrillary tangles and beta-amyloid plaques have been observed in the amygdala in Alzheimer disease. A disproportionate abundance of this abnormality in the amygdala may cause behavioral symptoms similar to Klüver-Bucy syndrome.
OBJECTIVES: To describe an atypical behavioral presentation of Alzheimer disease and to review the literature on the subject.
DESIGN: Case study.
SETTING: Outpatient specialty clinic. PATIENT: A 70-year-old man with progressive behavioral symptoms of hyperorality, hypersexuality, hypermetamorphosis, visual agnosia, hyperphagia, and apathy who died at age 77 of asphyxiation on a foreign object. MAIN OUTCOME MEASURES: Clinical symptomatology, brain imaging, and neuropathology.
RESULTS: The pathologic diagnosis was Alzheimer disease with abundant tangles and plaques in the lateral amygdala.
CONCLUSIONS: This case represents a variant of Alzheimer disease with prominent amygdala abnormalities and a Klüver-Bucy phenotype that was misdiagnosed as frontotemporal dementia. Clinical and imaging findings that may aid in accurate diagnosis are reviewed.

Entities:  

Mesh:

Year:  2009        PMID: 19139311      PMCID: PMC2868923          DOI: 10.1001/archneurol.2008.517

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

1.  Amygdala cell loss and atrophy in Alzheimer's disease.

Authors:  S A Scott; S T DeKosky; D L Sparks; C A Knox; S W Scheff
Journal:  Ann Neurol       Date:  1992-10       Impact factor: 10.422

2.  Klüver-Bucy syndrome after bilateral selective damage of amygdala and its cortical connections.

Authors:  L A Hayman; J L Rexer; M A Pavol; D Strite; C A Meyers
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1998       Impact factor: 2.198

Review 3.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

4.  Pathological alterations in the amygdala in Alzheimer's disease.

Authors:  L J Kromer Vogt; B T Hyman; G W Van Hoesen; A R Damasio
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

5.  Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour.

Authors:  A Burns; R Jacoby; R Levy
Journal:  Br J Psychiatry       Date:  1990-07       Impact factor: 9.319

Review 6.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

7.  Amygdaloid changes in aging and dementia.

Authors:  A G Herzog; T L Kemper
Journal:  Arch Neurol       Date:  1980-10

8.  Clinical and pathological evidence for a frontal variant of Alzheimer disease.

Authors:  J K Johnson; E Head; R Kim; A Starr; C W Cotman
Journal:  Arch Neurol       Date:  1999-10

9.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

Authors:  Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles S DeCarli; R Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
Journal:  Brain       Date:  2007-08-18       Impact factor: 13.501

10.  The amygdala in Alzheimer's disease: neuropathology and Alz 50 immunoreactivity.

Authors:  J W Unger; L W Lapham; T H McNeill; T A Eskin; R W Hamill
Journal:  Neurobiol Aging       Date:  1991 Sep-Oct       Impact factor: 4.673

View more
  6 in total

1.  Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity.

Authors:  Stéphane P Poulin; Rebecca Dautoff; John C Morris; Lisa Feldman Barrett; Bradford C Dickerson
Journal:  Psychiatry Res       Date:  2011-09-14       Impact factor: 3.222

2.  Coprophagia in neurologic disorders.

Authors:  Keith A Josephs; Jennifer L Whitwell; Joseph E Parisi; Maria I Lapid
Journal:  J Neurol       Date:  2016-03-26       Impact factor: 4.849

3.  Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition.

Authors:  Lilah M Besser; Michael L Alosco; Liliana Ramirez Gomez; Xiao-Hua Zhou; Ann C McKee; Robert A Stern; John Gunstad; Julie A Schneider; Helena Chui; Walter A Kukull
Journal:  J Neuropathol Exp Neurol       Date:  2016-08-11       Impact factor: 3.685

4.  Early Detection of Alzheimer's Disease Using Magnetic Resonance Imaging: A Novel Approach Combining Convolutional Neural Networks and Ensemble Learning.

Authors:  Dan Pan; An Zeng; Longfei Jia; Yin Huang; Tory Frizzell; Xiaowei Song
Journal:  Front Neurosci       Date:  2020-05-13       Impact factor: 4.677

5.  Association Between Amygdala Volume and Trajectories of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia With Lewy Bodies.

Authors:  Alberto Jaramillo-Jimenez; Lasse M Giil; Diego A Tovar-Rios; Miguel Germán Borda; Daniel Ferreira; Kolbjørn Brønnick; Ketil Oppedal; Dag Aarsland
Journal:  Front Neurol       Date:  2021-07-07       Impact factor: 4.003

6.  Diagnostic value of amygdala volume on structural magnetic resonance imaging in Alzheimer's disease.

Authors:  De-Wei Wang; Shou-Luan Ding; Xian-Li Bian; Shi-Yue Zhou; Hui Yang; Ping Wang
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.